ANIP News and Press, ANI Pharmaceuticals Inc. From 08/06/21

-- Second quarter 2021 net revenues of $48.6 million; net loss of $14.1 million and diluted loss per share of ($1.17) -- -- Second quarter adjusted non-GAAP EBITDA of $13.1 million and adjusted non-GAAP diluted earnings per share of $0.67 -- -- Refiled supplemental...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2021 financial results on Friday, August 6, 2021. Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Care...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Company has re-filed its supplemental new drug application (“sNDA”) for Cortrophin ® Gel with the U.S. Food and Drug Administration (“...

ANI's business growth rate could be on the cusp of a rapid acceleration. Free cash flow generation is on the upswing. Stock valuations are pricing in stagnant results, mimicking rear-view mirror thinking. I like the technical chart pattern - a rising price could launch the quo...

The following slide deck was published by ANI Pharmaceuticals, Inc. in conjunction with this event. For further details see: ANI Pharmaceuticals (ANIP) Presents At Raymond James Human Health Innovation Conference 2021 - Slideshow

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Raymond James Human Health Innovation Conference 2021 as follows: ...

ANI Pharmaceuticals, Inc. (“ANI“ or the “Company“) (Nasdaq: ANIP) today announced log-in details for its 2021 Virtual Annual Meeting of Stockholders to be held on June 2, 2021, beginning at 10 a.m. Eastern Time. Stockholders can attend the virtual annual ...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference 2021 as follows: The pr...

ANI Pharmaceuticals posted much better quarterly results than expected on Friday. This triggered a 15% rally in the stock that day, which the shares promptly gave back in yesterday's market sell-off. We dig into the numbers and update our investment thesis on this promising biopha...

ANI Pharmaceuticals, Inc. (ANIP) Q1 2021 Earnings Conference Call May 07, 2021 08:30 AM ET Company Participants Lisa Wilson - In-Site Communications, Investor Relations Nikhil Lalwani - President & Chief Executive Officer Stephen Carey - Chief Financial Officer Conference Call Participant...